| 34.73 Data as of 4:02pm ET |  +0.41 / +1.19%Today’s Change | 31.79 Today|||52-Week Range 39.10 | +1.25% Year-to-Date |
| Fresenius Teams with ApolloMed - Analyst Blog May 15 / Zacks.com |
| Previous close | 34.32 |
| Today’s open | 34.52 |
| Day’s range | 34.44 - 34.86 |
| Volume | 184,580 |
| Average volume (3 months) | 174,944 |
| Market cap | $20.8B |
| Dividend yield | 1.41% |
| Earnings growth (last year) | +10.46% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +9.10% |
| Revenue growth (last year) | +8.42% |
| P/E ratio | -- |
| Price/Sales | 1.51 |
| Price/Book | 2.35 |
| Today’s change | Today’s % change | |
|---|---|---|
| DVADaVita HealthCare Pa... | -0.55 | -0.44% |
| FMSPRFresenius Medical Ca... | 0.00 | 0.00% |
| Next reporting date | July 30, 2013 |
| EPS forecast (this quarter) | $0.46 |
| Annual revenue (last year) | $13.9B |
| Annual profit (last year) | $1.2B |
| Net profit margin | 8.60% |
Sector Health Services |
Industry Medical/Nursing Services |
Chairman-Management Board & CEO Rice Powell |
CEO- Global Manufacturing Operations Kent Wanzek |
Corporate headquarters Bad Homburg vor der Höhe, Hessen |
.
